114 related articles for article (PubMed ID: 38742345)
1. [Value of peripheral blood rare cell EGFR gene amplification detection in the evaluation of benign and malignant pulmonary nodules].
Li H; Liu XQ; Yan LJ; Liu Y; Zhang JQ; Xiao YN; Li SQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1584-1589. PubMed ID: 38742345
[No Abstract] [Full Text] [Related]
2. [Value of Combined Detection of Cytokines and Tumor Markers in the
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
[TBL] [Abstract][Full Text] [Related]
3. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
4.
Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
[TBL] [Abstract][Full Text] [Related]
5. CT-Assisted Improvements in the Accuracy of the Intraoperative Frozen Section Examination of Ground-Glass Density Nodules.
Xinli W; Xiaoshuang S; Chengxin Y; Qiang Z
Comput Math Methods Med; 2022; 2022():8967643. PubMed ID: 35035526
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Benign and Malignant Pulmonary Ground-Glass Nodules Using Computed Tomography Radiomics Parameters.
Liang L; Zhang H; Lei H; Zhou H; Wu Y; Shen J
Technol Cancer Res Treat; 2022; 21():15330338221119748. PubMed ID: 36259167
[No Abstract] [Full Text] [Related]
7. Estimation of malignancy of pulmonary nodules at CT scans: Effect of computer-aided diagnosis on diagnostic performance of radiologists.
Liu J; Zhao L; Han X; Ji H; Liu L; He W
Asia Pac J Clin Oncol; 2021 Jun; 17(3):216-221. PubMed ID: 32757455
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
[TBL] [Abstract][Full Text] [Related]
9. [Multivariate Analysis of Solid Pulmonary Nodules Smaller than 1 cm in
Distinguishing Lung Cancer from Intrapulmonary Lymph Nodes].
Tang J; Liu C; Wang P; Cui Y
Zhongguo Fei Ai Za Zhi; 2021 Feb; 24(2):94-98. PubMed ID: 33508896
[TBL] [Abstract][Full Text] [Related]
10. Novel and convenient method to evaluate the character of solitary pulmonary nodule-comparison of three mathematical prediction models and further stratification of risk factors.
Xiao F; Liu D; Guo Y; Shi B; Song Z; Tian Y; Liang C
PLoS One; 2013; 8(10):e78271. PubMed ID: 24205175
[TBL] [Abstract][Full Text] [Related]
11. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
[TBL] [Abstract][Full Text] [Related]
12. Developing a multi-institutional nomogram for assessing lung cancer risk in patients with 5-30 mm pulmonary nodules: a retrospective analysis.
Jiang Y; Deng T; Huang Y; Ren B; He L; Pang M; Jiang L
PeerJ; 2023; 11():e16539. PubMed ID: 38107565
[TBL] [Abstract][Full Text] [Related]
13. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
[TBL] [Abstract][Full Text] [Related]
14. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of computed tomography texture features between pulmonary inflammatory nodules and lung cancer].
E LN; Zhang N; Wang RH; Wu ZF
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):847-850. PubMed ID: 30481937
[No Abstract] [Full Text] [Related]
16. [The effective mutation of epidermal growth factor receptor in synchronous multiple primary lung cancers: study of clinical, radiographic and pathological factors].
Wang YJ; Feng H; Ma SR; Wang YC; Liu YY; Bai HJ; Zhao L
Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(29):2297-2301. PubMed ID: 31434406
[No Abstract] [Full Text] [Related]
17. Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression.
Ma SH; Le HB; Jia BH; Wang ZX; Xiao ZW; Cheng XL; Mei W; Wu M; Hu ZG; Li YG
BMC Cancer; 2008 Jun; 8():186. PubMed ID: 18590539
[TBL] [Abstract][Full Text] [Related]
18. Predictive model for the diagnosis of benign/malignant small pulmonary nodules.
Chen W; Zhu D; Chen H; Luo J; Fu H
Medicine (Baltimore); 2020 Apr; 99(15):e19452. PubMed ID: 32282697
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
20. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]